Stock PAR PARADIGM BIOPHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Paradigm Biopharmaceuticals Limited

Equities

PAR

AU000000PAR5

Delayed Australian S.E.
Other stock markets
 03:28:36 01/05/2024 BST 		5-day change 1st Jan Change
0.295 AUD +9.26% Intraday chart for Paradigm Biopharmaceuticals Limited +3.51% -30.59%
04-19 Paradigm Biopharmaceuticals Submits Documents to FDA for Phase 3 Osteoarthritis Program MT
02-28 Paradigm Biopharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Evolution of the average Target Price on Paradigm Biopharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

4dd.YkJ-u_TIfEzG-nrpKQyPArkkdCr7un17nCrhuTl89AY.Vm876ZyuC33rjkjQbk2-c45wWUy92y9J81uLwVgkwlknGxnWl_8GdLe9Sg~f3acd0f3fc1a13c78010363c8bef32dd

Analyst Recommendations on Paradigm Biopharmaceuticals Limited

Lingering Concerns on Economic Outlook, Rate Hikes Dampen Appetite for Australian Shares MT
Australian Shares Rise to One-Month High After US Fed Rate Hike MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.27 AUD
Average target price
2.295 AUD
Spread / Average Target
+750.00%
High Price Target
3.19 AUD
Spread / Highest target
+1,081.48%
Low Price Target
1.4 AUD
Spread / Lowest Target
+418.52%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PAR Stock
  4. Consensus Paradigm Biopharmaceuticals Limited